Insight into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracy
By Anand Shah MD & Jeff Shuren MD – As we at the FDA have said before, every step we have taken in our approach to COVID-19 testing has been a careful balancing of risks and benefits – all done to anticipate and meet continuing and evolving public health needs as we combat this virus.
Read More